TI
SLN

Trexquant Investment’s Silence Therapeutics SLN Stock Holding History

Trexquant Investment’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
+23,842
New +$168K ﹤0.01% 1763
2025
Q1 		– Sell
-63,663
Closed -$438K – 1856
2024
Q4 		$438K Buy
+63,663
New +$821K 0.01% 1317
2024
Q3 		– Sell
-21,803
Closed -$414K – 1830
2024
Q2 		$414K Buy
21,803
+756
+4% +$16.1K 0.01% 1295
2024
Q1 		$455K Buy
+21,047
New +$457K 0.01% 1178

Other funds holding SLN

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Trexquant Investment's SLN Position: Q2 2026 in Review

Trexquant Investment opened a new position in Silence Therapeutics (SLN) in Q2 2026: 23,842 shares worth $262K. The stake represents ﹤0.01% of the portfolio and ranks #1763 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in SLN as recently as Q4 2024.

Trexquant Investment first reported a position in SLN in Q1 2024 and has held it in 4 quarters since. The position peaked at $455K in Q1 2024. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Trexquant Investment held 23,842 shares of Silence Therapeutics worth $262K as of Q2 2026.
  • Silence Therapeutics was a new Trexquant Investment position in Q2 2026.
  • Silence Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1763 holding.
  • Trexquant Investment first reported a position in Silence Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Trexquant Investment's Silence Therapeutics position peaked at $455K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.